1. Sanofi (11 from 1,451 patents)

2. Aventis Pharma S.a. (4 from 377 patents)

3. Ucbbiopharma Srl (2 from 109 patents)

4. Ucb Biopharma Sprl (1 from 138 patents)

1. 11912721 - Fused pentacyclic imidazole derivatives

2. 11739100 - 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof

3. 11214541 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

4. 11149031 - Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof

5. 10906919 - Fused pentacyclic imidazole derivatives

6. 10570090 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

7. 10253043 - 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof

8. 10202405 - Fused pentacyclic imidazole derivatives

9. 9714221 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

10. 9321790 - Pyrimidinone derivatives as antimalarial agents

11. 8846670 - 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof

12. 8828997 - 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof

13. 8163768 - 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them

14. 7968566 - Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors

15. 7517902 - Substituted indazoles, compositions containing the same, and the preparation and use thereof